|Little Pharma |
Top U.S. biotech deals in 2003
|Johnson & Johnson||Scios||2.4 billion|
|King Pharmaceuticals||Elan||750 million|
|Axcan Pharma||Salix Pharmaceuticals||187 million|
|Source: Thomson Financial|
To date, there have been 11,264 announced deals worldwide for a total dollar value of $520.2 billion, compared to last year's 12,480 deals valued at $548.9 billion, according to Thomson Financial. The U.S. numbers paint an equally bleak picture. As of today, there were 3,270 announced domestic deals valued at $155.2 billion, compared to last year's 3,402 deals worth $191 billion.